Elite Pharmaceuticals, Inc. (ELTP)
0.263
+0.01
(+4.74%)
USD |
OTCM |
Sep 11, 16:00
Elite Pharmaceuticals Market Cap : 283.29M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 283.29M |
| September 10, 2026 | 270.47M |
| September 09, 2026 | 276.93M |
| September 08, 2026 | 279.95M |
| September 04, 2026 | 277.90M |
| September 03, 2026 | 281.24M |
| September 02, 2026 | 297.51M |
| September 01, 2026 | 306.66M |
| August 31, 2026 | 309.68M |
| August 28, 2026 | 311.13M |
| August 27, 2026 | 310.22M |
| August 26, 2026 | 306.98M |
| August 25, 2026 | 308.06M |
| August 24, 2026 | 311.40M |
| August 21, 2026 | 317.76M |
| August 20, 2026 | 320.39M |
| August 19, 2026 | 326.37M |
| August 18, 2026 | 326.91M |
| August 17, 2026 | 331.76M |
| August 14, 2026 | 333.91M |
| August 13, 2026 | 386.15M |
| August 12, 2026 | 387.77M |
| August 11, 2026 | 388.85M |
| August 10, 2026 | 387.86M |
| August 07, 2026 | 388.83M |
| Date | Value |
|---|---|
| August 06, 2026 | 385.28M |
| August 05, 2026 | 388.72M |
| August 04, 2026 | 393.03M |
| August 03, 2026 | 400.25M |
| July 31, 2026 | 408.11M |
| July 30, 2026 | 401.43M |
| July 29, 2026 | 400.25M |
| July 28, 2026 | 403.91M |
| July 27, 2026 | 414.68M |
| July 24, 2026 | 417.40M |
| July 23, 2026 | 403.91M |
| July 22, 2026 | 401.76M |
| July 21, 2026 | 408.22M |
| July 20, 2026 | 414.68M |
| July 17, 2026 | 418.18M |
| July 16, 2026 | 429.76M |
| July 15, 2026 | 403.80M |
| July 14, 2026 | 400.57M |
| July 13, 2026 | 393.14M |
| July 10, 2026 | 397.10M |
| July 09, 2026 | 394.97M |
| July 08, 2026 | 397.45M |
| July 07, 2026 | 391.57M |
| July 06, 2026 | 387.75M |
| July 02, 2026 | 367.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 2.335B |
| Daré Bioscience, Inc. | 11.14M |
| Eton Pharmaceuticals, Inc. | 1.628B |
| ANI Pharmaceuticals, Inc. | 1.616B |
| Corcept Therapeutics, Inc. | 12.05B |
Market Cap Related Metrics
| PE Ratio | 10.00 |
| PS Ratio | 2.093 |
| Price to Book Value | 2.702 |
| Price to Free Cash Flow | 16.84 |
| Price | 0.263 |
| Earnings Yield | 10.00% |
| Operating PE Ratio | 8.245 |
| Normalized PE Ratio | 32.47 |